However, BBB imaging studies have shown that older adults with cognitive dysfunction have BBB breakdown regardless of amyloid/tau biomarker changes,40, 41, 42 suggesting that CVR reduction may be a contributor to cognitive decline due to cerebrovascular disease that may or may not interact with AD pathologies. The gene discussed is MAPT; the disease is Alzheimer disease.